Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
9
69%
Ph phase_2
1
8%
Ph phase_3
2
15%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(4)
Other(8)

Detailed Status

unknown8
Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (8.3%)
Phase 32 (16.7%)
N/A9 (75.0%)

Trials by Status

unknown862%
completed431%
recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
PROCEDURE
Total Trials
13